艾伯维公司宣布将增设两座全新生产设施,通过引入尖端制造技术,大幅提升其在神经科学和肥胖治疗领域的下一代药物产能布局。这一战略投入将为企业长期发展注入强劲动力。
艾伯维公司宣布将增设两座全新生产设施,通过引入尖端制造技术,大幅提升其在神经科学和肥胖治疗领域的下一代药物产能布局。这一战略投入将为企业长期发展注入强劲动力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.